GCP
RLYB icon

GSA Capital Partners’s Rallybio RLYB Stock Holding History

GSA Capital Partners’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,413
Closed -$13K – 2096
2025
Q4 		$13K Buy
+2,413
New +$12.4K ﹤0.01% 1615

Other funds holding RLYB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

GSA Capital Partners's RLYB Position: Q1 2026 in Review

GSA Capital Partners sold out of Rallybio (RLYB) in Q1 2026, closing a stake of 2,413 shares — an estimated $13K sold.

GSA Capital Partners first reported a position in RLYB in Q4 2025 and held it in 1 quarter. The position peaked at $13K in Q4 2025. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • GSA Capital Partners reported no remaining Rallybio position as of Q1 2026 after selling out during the quarter.
  • GSA Capital Partners sold 2,413 Rallybio shares in Q1 2026, an estimated $13K.
  • GSA Capital Partners first reported a position in Rallybio in Q4 2025 and held it in 1 quarter.
  • GSA Capital Partners's Rallybio position peaked at $13K in Q4 2025.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.